MHRA Supports Launch Of Innovate UK’s First-of-its-kind Initiative To Fund New Regulatory Science And Innovation Networks
Health
Launched Wednesday 13 December by Innovate UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has joined partners across government including the Office for Life Sciences to provide support and invite academic institutions in the UK to apply to become a member of an RSIN.
In a drive to proactively deliver agile and robust regulatory pathways and guidance to support the innovators of today and tomorrow, the MHRA has helped shape the design of this program with partners across government, which will enable research informing the future of UK regulatory practice.
Applications can be made through UKRI’s Innovation Funding Service.
The program comprises two phases. Firstly, an open competition for a six-month Discovery Phase in which funding will be awarded to initial collaborations to build relationships and support exploratory work to develop full applications. This will be followed by the Implementation Phase, in which Discovery Phase collaborations will be invited to apply for full funding to establish their RSIN.
Further details on the Implementation Phase will be shared with applicants at an MHRA event following the Discovery Phase. The MHRA will also be providing support to members of health and life sciences themed RSIN members throughout the process.
Institutions interested in applying can join an online Innovate UK applicant briefing event via the competition page for more information – including eligibility requirements and the application process – and priority themes from vaccines and immunotherapies to AI and diagnostics.